106 related articles for article (PubMed ID: 9872012)
1. [New approaches for encapsulation of peptides into poly(lactic/glycolic acid) microspheres].
Blanco-Prieto MJ; Fattal E; Puisieux F; Couvreur P
Ann Pharm Fr; 1998; 56(6):256-63. PubMed ID: 9872012
[TBL] [Abstract][Full Text] [Related]
2. Multiple emulsion technology for the design of microspheres containing peptides and oligopeptides.
Fattal E; Roques B; Puisieux F; Blanco-Prieto MJ; Couvreur P
Adv Drug Deliv Rev; 1997 Oct; 28(1):85-96. PubMed ID: 10837566
[TBL] [Abstract][Full Text] [Related]
3. Changing the pH of the external aqueous phase may modulate protein entrapment and delivery from poly(lactide-co-glycolide) microspheres prepared by a w/o/w solvent evaporation method.
Leo E; Pecquet S; Rojas J; Couvreur P; Fattal E
J Microencapsul; 1998; 15(4):421-30. PubMed ID: 9651864
[TBL] [Abstract][Full Text] [Related]
4. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems.
Igartua M; Hernández RM; Esquisabel A; Gascon AR; Calvo MB; Pedraz JL
J Microencapsul; 1997; 14(3):349-56. PubMed ID: 9147284
[TBL] [Abstract][Full Text] [Related]
5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
6. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
He JT; Tao XM; Mo W; Song HY
Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
[TBL] [Abstract][Full Text] [Related]
7. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
8. PLGA microspheres for the ocular delivery of a peptide drug, vancomycin using emulsification/spray-drying as the preparation method: in vitro/in vivo studies.
Gavini E; Chetoni P; Cossu M; Alvarez MG; Saettone MF; Giunchedi P
Eur J Pharm Biopharm; 2004 Mar; 57(2):207-12. PubMed ID: 15018976
[TBL] [Abstract][Full Text] [Related]
9. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
10. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
11. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
12. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
13. In vitro ciprofloxacin release from poly(lactide-co-glycolide) microspheres.
Martinez B; Lairion F; Pena MB; Di Rocco P; Nacucchio MC
J Microencapsul; 1997; 14(2):155-61. PubMed ID: 9132467
[TBL] [Abstract][Full Text] [Related]
14. Biodegradation and biocompatibility of contraceptive-steroid-loaded poly (DL-lactide-co-glycolide) injectable microspheres: in vitro and in vivo study.
Dhanaraju MD; Rajkannan R; Selvaraj D; Jayakumar R; Vamsadhara C
Contraception; 2006 Aug; 74(2):148-56. PubMed ID: 16860053
[TBL] [Abstract][Full Text] [Related]
15. Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system.
Han Y; Tian H; He P; Chen X; Jing X
Int J Pharm; 2009 Aug; 378(1-2):159-66. PubMed ID: 19465100
[TBL] [Abstract][Full Text] [Related]
16. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of PLGA particles for subcutaneous controlled drug release by membrane emulsification.
Gasparini G; Kosvintsev SR; Stillwell MT; Holdich RG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):199-207. PubMed ID: 17919891
[TBL] [Abstract][Full Text] [Related]
18. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment.
Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK
Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243
[TBL] [Abstract][Full Text] [Related]
19. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
